MX2022002390A - Sistema para regular la expresion genica. - Google Patents

Sistema para regular la expresion genica.

Info

Publication number
MX2022002390A
MX2022002390A MX2022002390A MX2022002390A MX2022002390A MX 2022002390 A MX2022002390 A MX 2022002390A MX 2022002390 A MX2022002390 A MX 2022002390A MX 2022002390 A MX2022002390 A MX 2022002390A MX 2022002390 A MX2022002390 A MX 2022002390A
Authority
MX
Mexico
Prior art keywords
gene expression
present disclosure
regulating gene
regulation
nucleic acid
Prior art date
Application number
MX2022002390A
Other languages
English (en)
Spanish (es)
Inventor
Laising Yen
Liming Luo
Jocelyn Duen-Ya Jea
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Publication of MX2022002390A publication Critical patent/MX2022002390A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/16—Aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MX2022002390A 2019-08-30 2020-08-28 Sistema para regular la expresion genica. MX2022002390A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962894611P 2019-08-30 2019-08-30
US201962904635P 2019-09-23 2019-09-23
US202063043504P 2020-06-24 2020-06-24
PCT/US2020/048561 WO2021041924A2 (en) 2019-08-30 2020-08-28 System for regulating gene expression

Publications (1)

Publication Number Publication Date
MX2022002390A true MX2022002390A (es) 2022-05-13

Family

ID=74683442

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022002390A MX2022002390A (es) 2019-08-30 2020-08-28 Sistema para regular la expresion genica.

Country Status (11)

Country Link
US (1) US20220290147A1 (cg-RX-API-DMAC10.html)
EP (1) EP4022065A4 (cg-RX-API-DMAC10.html)
JP (2) JP7737152B2 (cg-RX-API-DMAC10.html)
KR (1) KR20220049619A (cg-RX-API-DMAC10.html)
CN (1) CN115279902A (cg-RX-API-DMAC10.html)
AU (1) AU2020335909A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022003512A2 (cg-RX-API-DMAC10.html)
CA (1) CA3152513A1 (cg-RX-API-DMAC10.html)
IL (1) IL290944A (cg-RX-API-DMAC10.html)
MX (1) MX2022002390A (cg-RX-API-DMAC10.html)
WO (1) WO2021041924A2 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2769991C2 (ru) 2015-11-12 2022-04-12 Байлор Колледж Оф Медсин Экзогенный контроль экспрессии генов млекопитающих с помощью опосредованной аптамерами модуляции полиаденилирования
US20260053851A1 (en) 2021-08-11 2026-02-26 Sana Biotechnology, Inc. Inducible systems for altering gene expression in hypoimmunogenic cells

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2305813A3 (en) * 2002-11-14 2012-03-28 Dharmacon, Inc. Fuctional and hyperfunctional sirna
EP1733034A4 (en) 2004-03-15 2010-01-20 Biogen Idec Inc METHOD AND CONSTRUCTS FOR THE EXPRESSION OF POLYPEPTIDE MULTIMERS IN EUKARYONTIC CELLS USING ALTERNATIVE SPLEISSEN
US20050282190A1 (en) * 2004-04-09 2005-12-22 Hua Shi Modular design and construction of nucleic acid molecules, aptamer-derived nucleic acid constructs, RNA scaffolds, their expression, and methods of use
CA2566286A1 (en) * 2004-05-11 2005-12-08 Rnai Co., Ltd. Polynucleotide causing rna interfere and method of regulating gene expression with the use of the same
US7825229B2 (en) * 2005-03-25 2010-11-02 Rosetta Genomics Ltd. Lung cancer-related nucleic acids
US8178503B2 (en) * 2006-03-03 2012-05-15 International Business Machines Corporation Ribonucleic acid interference molecules and binding sites derived by analyzing intergenic and intronic regions of genomes
US20150284738A1 (en) * 2006-12-29 2015-10-08 Rodina Holding S.A. Artificial dna sequence with optimized leader function in 5' (5'-utr) for the improved expression of heterologous proteins in plants
US20130157279A1 (en) * 2010-09-01 2013-06-20 Nec Corporation Method for detecting target substance and aptamer set, sensor, and apparatus used in the method
US20130239236A1 (en) * 2010-10-01 2013-09-12 R1 B3 Holdings B.V. Regulation of translation of expressed genes
EP2812436A4 (en) * 2012-02-10 2016-05-11 Univ Leland Stanford Junior MINI-INTRONIC PLASMID VECTORS
WO2013173637A1 (en) * 2012-05-16 2013-11-21 Rana Therapeutics, Inc. Compositions and methods for modulating gene expression
US9567581B2 (en) * 2012-08-07 2017-02-14 The General Hospital Corporation Selective reactivation of genes on the inactive X chromosome
WO2016126747A1 (en) 2015-02-02 2016-08-11 Meiragtx Uk Limited Regulation of gene expression by aptamer-mediated modulation of alternative splicing
CA2979229A1 (en) * 2015-03-11 2016-09-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Rp2 vectors for treating x-linked retinitis pigmentosa
RU2769991C2 (ru) * 2015-11-12 2022-04-12 Байлор Колледж Оф Медсин Экзогенный контроль экспрессии генов млекопитающих с помощью опосредованной аптамерами модуляции полиаденилирования

Also Published As

Publication number Publication date
JP7737152B2 (ja) 2025-09-10
EP4022065A4 (en) 2024-02-14
WO2021041924A2 (en) 2021-03-04
CA3152513A1 (en) 2021-03-04
CN115279902A (zh) 2022-11-01
JP2025118711A (ja) 2025-08-13
EP4022065A2 (en) 2022-07-06
US20220290147A1 (en) 2022-09-15
BR112022003512A2 (pt) 2022-05-17
KR20220049619A (ko) 2022-04-21
JP2022546408A (ja) 2022-11-04
IL290944A (en) 2022-04-01
WO2021041924A3 (en) 2021-04-08
AU2020335909A1 (en) 2022-04-14

Similar Documents

Publication Publication Date Title
CO2022009562A2 (es) Arn guía modificados para edición de genes
SA520411173B1 (ar) Pd-l1 عوامل ربط ترتبط بـ واستخدامها cd137
SA520420729B1 (ar) الأحماض النووية الريبوزية الدليلية المُعدلة لتصحيح الجين
MX2015016798A (es) Regulacion transcripcional guiada por acido ribonucleico.
CO2017011957A2 (es) Variantes de alfa-amilasa y polinucleótidos que codifican las mismas
BR112022009723A2 (pt) Anticorpos específicos para cd47, pd-l1, e usos dos mesmos
AR080873A1 (es) Anticuerpos contra factor de crecimiento epidermico (anti-erbb3 o anti-her3)
CO2017005842A2 (es) Anticuerpos heterodiméricos que se unen a cd3 y cd38
CO2018003973A2 (es) Proteínas de unión a pd-1 y métodos para usarlas
MX2019012311A (es) Metodos y composiciones para modificaciones geneticas dirigidas y metodos de uso.
MX2017001694A (es) Ligadores de nucleotidos modificados.
BR112017007770A2 (pt) cultura in vitro, população de hipscs, método para modificar um locus-alvo genômico, e, hipsc.
BR112016025519A2 (pt) engenharia genética in vivo com vetores de adenovírus
MX2017010746A (es) Composicion y metodos para la expresion regulada de un complejo de arn guia/endonucleasa cas.
EP4234689A3 (en) Split inteins with exceptional splicing activity
MX2016014235A (es) Biosintesis microbiana de ergotioneina.
MX382223B (es) Regulacion de expresion genica mediada por nucleasa.
EA201201264A1 (ru) Молекулы полинуклеотидов для регуляции генов у растений
AR093446A1 (es) Anticuerpos de antihemaglutinina y metodos de uso
MX2017007196A (es) Fibroblastos de embrion de pollo inmortalizados.
EA202190244A3 (ru) Сверхэкспрессия регуляторов пути n-гликозилирования для модуляции гликозилирования рекомбинантных белков
UY35724A (es) ?construcciones para expresar transgenes usando elementos reguladores de genes de ubiquitina de panicum?.
MX2018010771A (es) Moleculas de union al transcrito 7 similar a inmunoglobulina (ilt7) y metodos de uso de las mismas.
MX2017011198A (es) Biomarcadores para preeclampsia.
UY34842A (es) Formulaciones estabilizadas que contienen anticuerpos anti-dll4